-+ 0.00%
-+ 0.00%
-+ 0.00%

ALUMIS SHARES JUMP 17.2% TO $9.74 PREMARKET AFTER CO'S SKIN DISEASE DRUG MEETS MAIN GOAL OF TWO LATE STAGE TRIALS

Reuters·01/06/2026 12:08:34

Please log in to view news